Products
Latest News
FAQ
|
Search
Search
Filters
Clear All
Study Phase
Early Phase 1
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
Phase 4
Not Applicable
Recruitment Status
Recruiting
Not yet recruiting
Active, not recruiting
Completed
Suspended
Terminated
Withdrawn
Study Type
Interventional
Observational
Expanded Access
Others
Eligibility Sex
All
Female
Male
Healthy Volunteers
All
Include
Exclude
Found
1
clinical trials
|
View Analysis
Sort by:
Newest First
Short-course Radiotherapy or Long-course Chemoradiation Followed by mFOLFOXIRI Consolidation Chemotherapy for Organ Preservation in Low Rectal Cancer
Phase 2
Recruiting
Conditions
Rectal Neoplasms
Interventions
Radiation: Short-course radiotherapy
Drug: Irinotecan
Drug: Oxaliplatin
Drug: Calcium Formate
Radiation: Long-course chemoradiation
Drug: Fluorouracil
Drug: Capecitabine
Subscribe
First Posted Date
2024-05-16
Last Posted Date
2024-05-16
Lead Sponsor
Pei-Rong Ding
Target Recruit Count
66
Registration Number
NCT06417476
Locations
🇨🇳
651 Dongfeng Road East, Guangzhou, Guangdong, China
Subscribe
Prev
1
Next
© Copyright 2025. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy